[1]
“CLINICAL PROFILE AND TREATMENT RESULTS OF PATIENTS RECEIVING BPALM REGIMEN FOR DRUG-RESISTANT TUBERCULOSIS AT A TERTIARY CARE TEACHING HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY”, A-JMRHS, vol. 4, no. 2, pp. 1084–1089, Jun. 2026, doi: 10.65605/a-jmrhs.2026.v04.i02.pp1084-1089.